Condition: Testicular Cancer · Testicular Germ Cell Tumor · Quality of Life · Sponsor: Erasmus Medical Center
The currently developed implementation study aims to evaluate if a patient-led home-based follow-up approach is successful, improves quality of life, reduces anxiety and lessens fear of cancer recurrence during the years after treatment of certain types of testicular cancer.
This description comes directly from the study's public registry record.
Lissa Wullaert, MD · +316107042125 · l.wullaert@erasmusmc.nl
Kelly R. Voigt, MD · +316107042125 · k.voigt@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Erasmus Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05670938